Serum Free Light Chain Kinetics Is Predictive of Renal Response in Myeloma Patients With Renal Impairment—An ALLG Trial of Carfilzomib-Dexamethasone Therapy in Frontline and Relapse

- Ho, P. Joy, Spencer, Andrew, Mollee, Peter, Bryant, Christian E., Enjeti, Anoop K., Horvath, Noemi, Butcher, Belinda E., Trotman, Judith, Gibbs, Simon, Joshua, Douglas E.

Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies

- Campbell, Ashlea, Teh, Benjamin, Lane, Steven, Dickinson, Michael, Quach, Hang, Enjeti, Anoop K., Ku, Matthew, Gregory, Gareth, Hapgood, Gregory, Ho, Phoebe Joy, Cochrane, Tara, Cheah, Chan, Mulligan, Stephen, Greenwood, Matthew, Latimer, M, Berkahn, L, Wight, J, Armytage, T, Diamond, P, Tam, CS, Hamad, N, Ross, David M., Weinkove, Robert, Gilroy, Nicole, Gangatharan, Shane, Prince, Henry Miles, Szer, Jeff, Trotman, Judith

Detection of complex genomic signatures associated with risk in plasma cell disorders

- Berry, Nadine K., Dixon-McIver, Amanda, Scott, Rodney J., Rowlings, Philip, Enjeti, Anoop K.

CAVATAK (Coxsackievirus A21) displays potent oncolytic activity in BRAFV600E mutant melanoma cells resistant to selective BRAF kinase inhibitors

- Shafren, D. R., Farrelly, M., Croft, A. J., Davies, B., Stewart, J., Ingham, R., Quah, M. Y., Au, G., Hersey, P.

Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy

- Nath, Christa E., Shaw, Peter J., Presgrave, Peter, Tiley, Campbell, Joshua, Douglas, Earl, John, Trotman, Judith, Zeng, Lihua, Duffull, Stephen B., Hegarty, Gareth, McLachlan, Andrew J., Gurney, Howard, Kerridge, Ian, Kwan, Ylu Lam